For results that have...

But don't include...

Epidemiology & Statistics
MISSION: Epidemiology & Statistics
The purpose of the American Diabetes Association Interest Group on Epidemiology & Statistics is to stimulate the exchange of information about the epidemiology of diabetes, and to foster the application of epidemiologic methods to research on the etiology and pathogenesis of diabetes and its complications. 

Caroline S. Fox, MD, MPH
Chair, Epidemiology & Statistics Interest Group
Medical Officer, Framingham Heart Study, National Heart, Lung and Blood Institute
Assistant Clinical Professor of Medicine, Harvard Medical School



Don't miss these
opportunities to 
GET INVOLVED!


Sign up! Receive 





New! Digital Media by Interest Group Members 

Webcast: Debate: Screening for Subclinical Cardiovascular Disease in Diabetes -- PRO Presentation
by Nathan D. Wong, MD
Webcast: Moving Beyond Traditional Epidemiologic Research 
by Judith E. Fradkin, MD
Webcast:  Time to Retire "Microalbuminuria" -- Early, Progressive Renal Decline Is the New Paradigm (Kelly West Award Lecture) by Andrzej S. Krolewski, MD, PhD
  
Webcast: Debate: Screening for Subclinical Cardiovascular Disease in Diabetes -- CON Presentation
by Silvio E. Inzucchi, MD
Webcast: Hot Issues Session: Association Between Serum Levels of Omentin, Categories of Glucose Tolerance, and Metabolic Risk Factors of Type 2 Diabetes: Results from the KORA F4 Study 
by Christian Herder, PhD
ePoster: Maternal Glucose Mediates the Association between Maternal BMI and Neonatal Adiposity: The Healthy Start Study (Michaela Modan Award Winner) by Allison Buti, et al.

Popular Books by Interest Group Members

 

Upcoming Meetings 

SAVE THE DATE! Plan to join your colleagues and leading diabetes experts in New York City on February 27-March 1, 2015. Discover the latest advances in diabetes treatment and management through interactive, small-group presentations.



Kelly M. West Award Lecture

Given in memory of Kelly M. West, widely regarded as the "father of diabetes epidemiology”, to an individual who has made significant contributions to the field of diabetes epidemiology. NOMINATIONS should be directed to Mary Merkin, Manager, Scientific and Medical at mmerkin@diabetes.org

 

Previous Award Winners:

2014 Andrzej S. Krolewski, MD, PhD

2013 Edward J. Boyko, MD, MPH

2012 Knut Borch-Johnsen, MD, PhD                       

2011 Frederick L. Brancati, MD, MHS, FACP         

2010 Frank B. Hu, MD, PhD

2009 James B. Meigs, MD, MPH

2008 Markku Laakso, MD, PhD

2007 Beverly Balkau, PhD, BSC, Dip Ed

2006 William H. Herman, MD, MPH

2005 Marian J. Rewers, MD, PhD

2004 Michael Engelgau, MD, MS

2003 Barbara V. Howard, PhD

2002 David H. Pettitt, MD

2001 John H. Fuller, MD

2000 Eveline Eschwege, MD 

1999 Wilfred Y. Fujimoto, MD

1998 Jaakko Tuomilehto, MD, PhD

1997 Steven M. Haffner, MD

1996 Richard F. Hamman, MD, DrPh

1995 William C. Knowler, MD, DrPh

1994 Ronald Klein, MD, MPH

1993 Trevor J. Orchard, MD

1992 Maureen I. Harris, PhD

1991 Paul Zimmet, MD, PhD

1990 Michael Stern, MD

1989 Harry Keen, MD

1988 Ronald E. LaPorte, PhD

1987 Elizabeth L. Barrett-Connor, MD

1986 Peter H. Bennett, MD


Michaela Modan Memorial Award

The scientists authoring the abstracts listed below have been awarded the Michaela Modan Award given in honor of Dr. Michaela Modan, an Israeli epidemiologist who made major contributions to the understanding of type 2 diabetes mellitus, insulin resistance, hypertension, and diabetic complications.


2014 - Maternal Glucose Mediates the Association between Maternal BMI and Neonatal Adiposity - The Healthy Start Study


2013 - Trends in All-Cause Mortality in Mid-life Over Four Decades: Effect of Adolescent Body-Mass Index


2012 - The GLP-1 Metabolite GLP 9-37 Increases Atherosclerotic Lesions in Mice and is Associated with Coronary Atherosclerosis in Humans

 

2011-Domain-Specific Cognitive Function and Fine Motor Speed in Women 65 Years and Older with Type 2

Diabetes Mellitus – Results from the Women’s Health Initiative Study of Cognitive Aging

 

2010 -A Genetic Risk Score to Improve the Prediction of Coronary Heart Disease in Type 2 Diabetes

 

2009 -Effect of Fenofibrate on Cardiovascular Events and Mortality in Women with Type 2 Diabetes – ResultsFrom the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

 

2008 - Gestational Diabetes Increases the Risk of Cardiovascular Disease in Young Women